Frank van Leth

Associate Professor Health Sciences

Pharmacokinetics of Nevirapine: Once-Daily Versus Twice-Daily Dosing in the 2NN Study


Journal article


B. Kappelhoff, A. Huitema, F. van Leth, P. Robinson, T. Macgregor, J. Lange, J. Beijnen
HIV Clinical Trials, 2005

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Kappelhoff, B., Huitema, A., van Leth, F., Robinson, P., Macgregor, T., Lange, J., & Beijnen, J. (2005). Pharmacokinetics of Nevirapine: Once-Daily Versus Twice-Daily Dosing in the 2NN Study. HIV Clinical Trials.


Chicago/Turabian   Click to copy
Kappelhoff, B., A. Huitema, F. van Leth, P. Robinson, T. Macgregor, J. Lange, and J. Beijnen. “Pharmacokinetics of Nevirapine: Once-Daily Versus Twice-Daily Dosing in the 2NN Study.” HIV Clinical Trials (2005).


MLA   Click to copy
Kappelhoff, B., et al. “Pharmacokinetics of Nevirapine: Once-Daily Versus Twice-Daily Dosing in the 2NN Study.” HIV Clinical Trials, 2005.


BibTeX   Click to copy

@article{b2005a,
  title = {Pharmacokinetics of Nevirapine: Once-Daily Versus Twice-Daily Dosing in the 2NN Study},
  year = {2005},
  journal = {HIV Clinical Trials},
  author = {Kappelhoff, B. and Huitema, A. and van Leth, F. and Robinson, P. and Macgregor, T. and Lange, J. and Beijnen, J.}
}


Share

Tools
Translate to